Berotralstat 150mg capsules
NHS hospitals in England used £21,172,459 of indicative cost of Berotralstat 150mg capsules in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is down 4.9% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Berotralstat 150mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Berotralstat 150mg capsules most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Barts Health Nhs Trust | £3,206,557 |
| Oxford University Hospitals Nhs Ft | £3,071,705 |
| University Hospital Southampton Nhs Ft | £1,928,745 |
| Leeds Teaching Hpls Nhs Trust | £1,357,265 |
| Cambridge Univ Hosp Nhs Foundation Trust | £1,265,420 |
| Nottingham University Hospitals Trust | £938,860 |
| Hull And East Yorkshire Hpls Nhs Trust | £918,450 |
| Univ Hpl B/Ham Nhs Foundation Trust | £826,605 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £765,375 |
| Western Sussex Hospitals Nhs Found Trust | £755,170 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.